CaniShot K5-Cv
Live Canine Distemper Virus, Canine Adenovirus type-2, Canine Parvovirus and Canine Parainfluenza Virus Combined Freeze Dried Vaccine
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- CaniShot
- Payment Terms
- L/C,Others,T/T
- Production method
- Available,OEM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- animal vaccine, canishot, canine vaccine, k5-cv
- Category
- Veterinary Medicine
Apply a video call to the Supplier
ChoongAng Vaccine Laboratories Co., Ltd.(CAVAC)
South Korea
- Verified Certificate
-
16
| Product name | CaniShot K5-Cv | Certification | - |
|---|---|---|---|
| Category | Veterinary Medicine | Ingredients | CANINE ADENOVIRUS TYPE 2,CANINE DISTEMPER VIRUS,CANINE PARAINFLUENZA VIRUS,CANINE PARVOVIRUS,INACTIVATED CANINE CORONAVIRUS |
| Keyword | animal vaccine , canishot , canine vaccine , k5-cv | Unit Size | - |
| Brand name | CaniShot | Unit Weigh | - |
| origin | South Korea | Stock | 0 |
| Supply type | Available,OEM | HS code | 300230 |
Product Information
Comprehensive vaccine for pet dogs including coronavirus
CaniShot® K5-Cv
Indication
An aid in the control and prevention of canine distemper, infectious canine hepatitis,
parvovirus infection, infectious tracheobronchitis, and coronavirus infection in dogs.
Composition and quantity (per dose)
CaniShot® K5
Canine distemper virus (Rockborn strain)……………….....≥103.5TCID50
Canine adenovirus type 2 (Manhatten strain)……………...≥103.0TCID50
Canine parvovirus (780916-LP strain)….…………………...≥105.0TCID50
Canine parainfluenza viru (D008 strain)…………………… ≥104.0TCID50
Stabilizer……………………………………………………......20%
CaniShot® Cv
Inactivated canine coronavirus (K-378 strain)………….....≥106.0TCID50
Adjuvant………………………………………………………..10%
Features
Excellent prevention against viral enteritis
- Prevents parvovirus+coronavirus at once
Original antigen from Dr. L. E. Carmichael who first developed parvovirus vaccine is used.
High immunogenicity against parvovirus.
Minimizes the interference of maternal antibody.
Reduces the frequency of vaccination.
Rockborn antigen with almost 100% protection is used.
Administration and dosage
1) Dilute 1 dose of CaniShot® K5 with 1 dose of CaniShot® Cv.
2) Administer 1.0㎖ subcutaneously or intramuscularly twice at dogs older than 6 weeks of age
and 3~4 weeks after 1st vaccination.
3) Booster vaccination : once every year
Packaging unit
1) 1 dose of CaniShot® K5
2) 1 dose of CaniShot® Cv
- Product Info Attached File
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other,Ocean Shipping |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | L/C,Others,T/T | Shipping time | Negotiable |
- President
- Injoong Yoon
- Address
- 1476-37 Yuseong-daero, Yuseong-gu, Daejeon, Korea
- Product Category
- Veterinary Medicine
- Year Established
- 1968
- No. of Total Employees
- 101-500
- Company introduction
-
As an innovative animal vaccine company, CAVAC’s long journey with continuing efforts
CAVAC leads the way in animal health
CAVAC is a powerful leader in the field of animal biological products. We provide a wide range of groundbreaking pharmaceutical products that promote animal health and welfare, as well as improving the quality of life of people in Korea.
CAVAC’s long history and continued efforts
Since it was founded in 1968, CAVAC has grown to become renowned in Korea as a developer and manufacturer of animal vaccines. With over 80 animal vaccine products, the company is a key player in the Korean and global markets. We have achieved multiple vendor audits conducted by multinational companies and government audits. CAVAC is also committed to finding better solutions for pharmaceutical, biological and diagnostic products, and strives to be a pioneering partner offering a wide range of services.
Global bio leader in the advanced animal vaccine industry
As an animal vaccine company, CAVAC has experienced accelerated growth. As well as enhancing the development of new products and technologies, we have maximized our investments to protect against challenges and competition from various global companies. CAVAC is strategically located in the Daedeok Innopolis, also known as the Silicon Valley of Korea, and has teamed up with a number of prominent research institutions. CAVAC is now expanding onto the global market and is striving to become one of the top 10 global partners in animal health.
- Main Markets
-
Bangladesh
Cambodia
Indonesia
Myanmar
Nepal
Pakistan
Philippines
Thailand
Viet Nam
- Factory Information
-
(주)중앙백신연구소,
주식회사 중앙백신연구소
- Main Product
